About: Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2000 (uk) im August 2000 veröffentlichter wissenschaftlicher Artikel (de) article scientifique publié en août 2000 (fr) artículu científicu espublizáu n'agostu de 2000 (ast) scientific article published on 01 August 2000 (en)
publication date	wds:Q74171252-0E33748A-B50F-4EE1-86DC-83DF6AB5E0D0
publication date	2000-08-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q74171252-26D08ACA-E796-46BD-B144-DE70E2A1CCF2
exact match	https://scigraph.springernature.com/pub.10.1038/sj.leu.2401843
cites work	wds:Q74171252-029792C5-8EE4-4966-8AE9-C8EA51D19213 wds:Q74171252-1A6398A1-E2B0-4C3F-BEA7-FB9A8CE303C3 wds:Q74171252-1F418635-3B83-4CA3-94D6-71DE636253FE wds:Q74171252-3E58F732-8B04-40D4-8F73-81EBC5164B19 wds:Q74171252-4B37B0DA-7C71-402D-893E-723F4EFB3BAA wds:Q74171252-51ABBB93-E4BB-4EE6-916F-02E14F8D73FA wds:Q74171252-5A88C95D-A146-4096-9D4D-3BE1E5A36C8C wds:Q74171252-5AB50772-7674-4A25-AF07-CF67491BD30B wds:Q74171252-845DCDF8-A16B-446A-8A19-2DAE0A654FB8 wds:Q74171252-8C143722-7D68-4103-B5F0-53784FDB4F11 wds:Q74171252-9DBD6F8E-6E74-4254-94C3-C218DD11E5EA wds:Q74171252-A3BDEC6C-0E9F-47FC-9F45-711C5C8EB224 wds:Q74171252-ACA93E3D-8ECB-4985-9C69-20AA9476E0D3 wds:Q74171252-B99977A3-0AEA-470F-86F7-88D29C037BBC wds:Q74171252-BCB24F09-889E-4DCF-8ABC-038DF4203B0F wds:Q74171252-E43DEF3B-230A-4D55-A9B6-5C4F9A75853F wds:Q74171252-E44B9CB0-1D8C-4A64-ADCD-4BE55B2953F7 wds:Q74171252-E993C472-C7DE-45F3-969F-FE8B1FBC2C88 wds:Q74171252-EA8571B9-751D-4617-8265-7B8ED1884C28 wds:Q74171252-F7F60C5A-FE97-4B56-B645-D549AFED20E2
cites work	15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. A variant form of hypergranular promyelocytic leukemia (M3) All-trans-retinoic acid in acute promyelocytic leukemia DNA sequencing with chain-terminating inhibitors Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine. Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group High dose cytosine arabinoside in the management of refractory acute leukaemia. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia Phase I-II trial of mitoxantrone in acute leukemia: an interim report Accumulation of S-phase cells in the bone marrow of patients with acute leukemia by cytosine arabinoside Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: a high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment Role of maintenance chemotherapy in acute promyelocytic leukemia. Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. The AML Cooperative Group
author name string	wds:Q74171252-0C80040A-896D-4B61-A201-8252514C31F1 wds:Q74171252-0DB9A4F4-8F64-4EE0-8671-553A0475A93C wds:Q74171252-11BAA3AF-0913-489C-84DE-AA31B141098F wds:Q74171252-30180DE0-7383-4645-82D1-CC9F27874D59 wds:Q74171252-34C73A53-13FD-4BCF-93AF-B4ED2357715B wds:Q74171252-38273880-0116-48FE-9C45-F30EF6E02B0E wds:Q74171252-3E5B4DBA-0D45-4EEF-9F77-EE8637FCECCD wds:Q74171252-47CED34F-C0FD-4C77-8C31-A265C5D94E19 wds:Q74171252-5294FDE1-0F7D-4DE1-A6AA-6C0EB439470F wds:Q74171252-61AFE046-AA71-40DE-9095-B69F0343D29C wds:Q74171252-63CD34D5-17FF-451C-A19E-FAC0FDBC7761 wds:Q74171252-64EF213D-A1D1-4252-A9A7-7A47845BDF05 wds:Q74171252-70B406FF-4F88-4F7B-8205-F74ABA8C33CF wds:Q74171252-7E83D220-1F96-425A-97B9-CB0B95290B4E wds:Q74171252-816ED0B7-89C2-4484-B5C6-809DC4CE8A1F wds:Q74171252-AD417AA4-F07D-4EE5-BAB0-33841931F70F wds:Q74171252-C5E90C17-A2C0-47B7-B06E-5CA33A7B2975 wds:Q74171252-D370D4CE-0249-4699-88C3-26DCD2F5BC51 wds:Q74171252-E9EEA62E-A9B1-4B44-9877-A4765D626694 wds:Q74171252-EA9D2B64-EB02-44A6-9739-32D61751FFF3 wds:Q74171252-F03DF738-545F-4C9F-AB2C-893378D45D3C wds:Q74171252-F9A5A998-C52C-426E-82A3-A41E97BD677A
author name string	R Hehlmann A Hochhaus A Heyll C Aul H Löffler W Hiddemann T Büchner P Staib T Haferlach D Haase C Fonatsch D Beelen B Wörmann S Saussele A Heinecke E Lengfelder C Schoch W D Ludwig W Gassmann W Seifarth A Reichert M C Sauerland
rdfs:label	Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group (en) Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group (nl)
skos:prefLabel	Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group (en) Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group (nl)
name	Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software